Clinical Trials
37 trialsBrentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
Northwestern University
A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma
St. Jude Children's Research Hospital
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
City of Hope Medical Center
Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy
University of Washington
Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer
Thomas Jefferson University
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Stanford University
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Ohio State University Comprehensive Cancer Center
Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
University of Utah
FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging
University of Washington
PET Scan in Treating Patients With Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center
Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors
University of Utah
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
Stanford University
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
University of Washington
ACRIN6682
American College of Radiology
PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma
Northwestern University
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Vanderbilt-Ingram Cancer Center
Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma
Fox Chase Cancer Center
F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy
University of Washington
Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer
Abramson Cancer Center at Penn Medicine
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Alliance for Clinical Trials in Oncology
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)
Abramson Cancer Center at Penn Medicine
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer
Case Comprehensive Cancer Center
PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer
Case Comprehensive Cancer Center
Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography
Washington University School of Medicine
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
University of Washington
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Stanford University
18F-FSPG PET/CT for Cancer Patients on Therapy
Stanford University
Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Boston Medical Center
Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
Stanford University
PET/CT Evaluation of Treatment Response in Breast Cancer
Vanderbilt-Ingram Cancer Center
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Stanford University
Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
University of Washington
Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer
Stanford University
FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
University of Washington
Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
Ohio State University Comprehensive Cancer Center
2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer
Ohio State University Comprehensive Cancer Center
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Children's Hospital of Philadelphia